Elevance Health (ELV) Fundamentals 2026 — P/E 17.2x, Revenue Analysis | SniperIQ
Elevance Health (ELV) is a US-listed Healthcare company in Medical - Healthcare Plans with a market capitalization of $84.1B, trading at
Elevance Health (ELV) is a US-listed Healthcare company in Medical - Healthcare Plans with a market capitalization of $84.1B, trading at
Elevance Health (ELV) has a market capitalization of approximately $84.1B, trading at
Elevance Health's trailing twelve-month P/E ratio is 17.2x, with a price-to-book (P/B) of 1.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
Elevance Health runs a net profit margin of 2.5%, a gross margin of 39.0%, and an operating margin of 3.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
Elevance Health reported revenue of
Elevance Health offers a trailing dividend yield of about 1.8%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Elevance Health carries a debt-to-equity ratio of 0.69x and a current ratio of 1.52x, with a market beta of 0.68. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Elevance Health (ELV) the key facts are: market cap $84.1B, P/E 17.2x, revenue
Get Elevance Health's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.